Cannawire Article on FDA CBD Hearing

by | Jun 5, 2019

cannawire

Article Date:

June 3, 2019

Location:

Cannabiswire

Featuring:

Sheri Orlowitz

Link:

Click Here

Cannawire Features Sheri Orlowitz’s Participation in FDA Hearings on CBD

 

Cannawire features Artemis Holdings. Sheri Orlowitz with the Marijuana Policy Project, a group that has helped pass many of the medical and adult use cannabis laws in the US over the decades, cautioned against creating an “unduly restrictive” regulatory framework as it could once again lead to illegal cannabis markets.

“No more back alley sales. The retailer needs to have confidence in what they’re selling and the consumer needs to have confidence in what they’re buying.”

 

Securities through Camden Financial Services, Member FINRA / SIPC , located at 10990 Wilshire Blvd., Suite 1200, Los Angeles, CA. 310-393-6632. Artemis Holdings and Camden Financial Services are not affiliated. Check the background of this investment professional on FINRA's BrokerCheck